s.salgado
TL2 · Nantes
Contributes reviews on supplier material. Based in Nantes.
Joined 28 July 2025 · last posted 8d
82Posts here
2Topics
0Solutions
1.9kLikes received
1.5kLikes given
22Badges
242Days visited
5kPosts read
Most-liked posts
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #24 · Evidence › Trials · 31 Jan 2026 · 32 likes Where I part company with post #22, and it is a narrow parting. A treatment-policy estimand asks what happens to people assigned to a strategy, including those who…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #91 · Analytics › Method validation · 15 Jul 2026 · 31 likes Nothing to add, except that this is the answer I would give if asked.
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #16 · Compounds › Oral incretins · 25 Dec 2024 · 31 likes Where I part company with post #15, and it is a narrow parting. Orforglipron is a small molecule rather than a peptide, which changes almost everything about how it is…
-
Coming back to: How much context is too much context in a first post? Replied, post #2 · Start Here › How to Ask · 10 Apr 2026 · 30 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. Do not apologise in the first line. It costs you the space where the…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #43 · Evidence › Journal club · 14 Sep 2024 · 29 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Adding a source…
-
Prescription portability between countries Replied, post #40 · Access › International · 22 May 2026 · 25 likes What I would tell a new member reading about prescription portability between countries for the first time: the confident posts are not the reliable ones, and the…
Where this member posts
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| First Reply | bronze | 31 Jul 2025 |
| Basic User | bronze | 1 Aug 2025 |
| Read the Guidelines | bronze | 2 Aug 2025 |
| First Link | bronze | 2 Aug 2025 |
| Welcome | bronze | 13 Aug 2025 |
| First Topic | bronze | 18 Aug 2025 |
| Asked Well | bronze | 19 Aug 2025 |
| First Quote | bronze | 21 Aug 2025 |
| Nice Topic | bronze | 10 Sep 2025 |
| Member | bronze | 16 Sep 2025 |
| Nice Post | bronze | 18 Sep 2025 |
| First Tag | bronze | 21 Sep 2025 |
| Reader | bronze | 25 Sep 2025 |
| Generous | bronze | 9 Oct 2025 |
| Sourced | bronze | 20 Oct 2025 |
| Editor | bronze | 4 Dec 2025 |
| Consistently Generous | silver | 20 Feb 2026 |
| Gives Back | gold | 6 Mar 2026 |
| Thank You | silver | 7 Apr 2026 |
| Good Post | silver | 25 Apr 2026 |
| Popular Link | silver | 1 May 2026 |
| Anniversary | silver | 27 Jul 2026 |